In this instance I'd look to 'value' of shares more than 'volume'of shares, eg $36,270 isn't earth shattering.
That said, movement up and the Carl Zeiss Meditec EANS 2018 showcase are all positive.
As I've said before, I regard this as an investment in CZM not Optiscan.
EANS 2018, page-3
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.010(6.45%) |
Mkt cap ! $129.4M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 16.0¢ | $23.08K | 143.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49548 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 73836 | 2 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| OIL (ASX) Chart |
